Targeting Pancreatic Cancer Stem Cells
Journal Title: Journal of Cancer Sciences - Year 2015, Vol 2, Issue 1
Abstract
Carcinomas of an epithelial-origin account for the majority of all malignant cancers worldwide. As the most common pancreatic cancer, Pancreatic Ductal Adeno Carcinoma (PDAC) is a carcinoma with an extremely high lethality [1-3]. Compared to other cancers originating in the digestive system, the therapeutic outcome of PDAC treatment is the least promising, largely resulting from a lack of symptoms at the early stages of PDAC and a lack of sensitive diagnostic biomarkers and effective treatments [1-3].
Authors and Affiliations
Xiangwei Xiao
Keywords
Related Articles
- EP ID EP207048
- DOI 10.13188/2377-9292.1000005
- Views 118
- Downloads 0
Association of Hepatitis C with Hepatocelluar Carcinoma: A Cross-Sectional Study from Northern Pakistan
Aim:Hepatocellular Carcinoma (HCC) is one of the most deleterious among cancer types which is associated with high morbidity and mortality. The disease more commonly affects men usually in their fifth and sixth decade of...
Microarray Based Genotyping: A Review
Microarray technology has become a very popular tool in the realm of current molecular biology tools, and combined with the increasing knowledge and accuracy gained by advances in human genome sequencing, this technique...
Targeted Therapy in Advanced Gastric Cancer: An Updated Review
Despite great efforts over the years, adenocarcinoma of the stomach remains a difficult disease to manage. It is the second leading cause of cancer death and is the fifth most common cancer worldwide. If diagnosed early,...
Massive Intra-Tumor Hemorrhage during Induction Chemotherapy in Neuroblastoma: A Case Series Report
We describe 5 children with high risk neuroblastoma (NB) who, during the induction phase of therapy, were admitted with circulatory shock because of massive intra-tumor bleeding. Patient’s intensive supportive care with...
High Dose Vitamin C and Low Dose Chemo Treatment
Research has shown that intravenous high dose vitamin C in cancer therapy cannot be dismissed but that it warrants further investigation. Recent studies have made more inroads into the understanding of the role of vitami...